Linked Data API

Show Search Form

Search Results

1699274
registered interest false more like this
date less than 2024-03-27more like thismore than 2024-03-27
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Physician Associates more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 25 March (HL2978), why they have specified how physician associates (PAs) are to be used, specifically with undifferentiated patients, rather than allowing GP practices to make their own decisions about the use of PAs. more like this
tabling member printed
Baroness Bennett of Manor Castle remove filter
uin HL3652 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-05more like thismore than 2024-04-05
answer text <p>Physician Associates (PAs) work within a defined scope of practice and limits of competence. NHS England has provided recent guidance on the use of PAs in general practice (GP) teams. As set out in the Network Contract Directed Enhanced Service, PAs should be adequately supervised by a GP when providing care for undifferentiated patients.</p><p>In terms of employment choices, GPs are self-employed contractors to the National Health Service, and it is largely up to employers to determine how best to staff their primary care network or GP, to best meet the needs of their population.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-05T13:32:33.723Zmore like thismore than 2024-04-05T13:32:33.723Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
4719
label Biography information for Baroness Bennett of Manor Castle more like this
1699317
registered interest false more like this
date less than 2024-03-27more like thismore than 2024-03-27
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Fertilisers more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what consideration they have given to the regulation, or other oversight, of the sale of plant biostimulants, including consideration of their efficacy, safety and ecological impacts. more like this
tabling member printed
Baroness Bennett of Manor Castle remove filter
uin HL3653 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-12more like thismore than 2024-04-12
answer text <p>The existing UK regulatory regime for the manufacture and placing of fertilisers on the market in the UK is fragmented and in need of modernisation. There are currently no specific requirements for plant biostimulants in domestic fertilisers legislation. However, Defra intends to improve on this by consolidating and streamlining the statute book and putting in place a conformity assessment framework for fertilisers. The framework will smooth the route to market for new and innovative products which are less polluting to the environment or are less resource intensive in their creation.</p><p>To support reform of fertilisers legislation Defra has funded a review of the evidence for the safe and effective use of plant biostimulants and a review of methods for evaluating methods for verifying the efficacy of plant biostimulants.</p><p>The potential impact of a chemical on plant health, including soil microbiomes is already considered, as appropriate, as part of HSE’s robust risk assessment process for pesticides and for biocides. In our regulatory programmes we do not assess the impacts of chemicals specifically on human and animal microbiomes and are not currently considering the introduction of such measures.</p>
answering member printed Lord Douglas-Miller more like this
question first answered
less than 2024-04-12T10:10:43.017Zmore like thismore than 2024-04-12T10:10:43.017Z
answering member
5006
label Biography information for Lord Douglas-Miller more like this
tabling member
4719
label Biography information for Baroness Bennett of Manor Castle more like this
1699318
registered interest false more like this
date less than 2024-03-27more like thismore than 2024-03-27
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Chemicals: Regulation more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the case for incorporating into pharmaceutical, pesticide and other chemical regulation consideration of impacts on human, animal, plant and soil microbiomes. more like this
tabling member printed
Baroness Bennett of Manor Castle remove filter
uin HL3654 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-09more like thismore than 2024-04-09
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates a robust programme of regulating and monitoring medicines to ensure patients have access to safe and effective medicines. While the microbiome is still an evolving field, the MHRA is working to further our understanding on the impact of pharmaceuticals on the microbiome. Experts in MHRA are leading on international efforts to improve understanding of this area, for example through the development of World Health Organisation reference reagents for the microbiome.</p><p> </p><p>The potential impact of a chemical on plant health, including soil microbiomes is already considered, as appropriate, as part of the Health and Safety Executive (HSE)’s robust risk assessment process for pesticides and for biocides.</p><p> </p><p>The legislation around veterinary medicines makes it clear that when considering the authorisation of antimicrobial substances for use in animals, there should be consideration of the impacts on the human, target animal, and environmental microbiomes, including plants and soils.</p>
answering member printed Lord Douglas-Miller more like this
question first answered
less than 2024-04-09T11:12:25.547Zmore like thismore than 2024-04-09T11:12:25.547Z
answering member
5006
label Biography information for Lord Douglas-Miller more like this
tabling member
4719
label Biography information for Baroness Bennett of Manor Castle more like this